This announcement is a separate document:
双成药业：海南双成药业股份有限公司董事会关于本次交易符合《上市公司重大资产重组管理办法》第十一条和第四十三条规定的说明
Shuangcheng Pharmaceutical: Instructions of the board of directors of Hainan Shuangcheng Pharmaceutical Co., Ltd. that the transaction complies with the provisions of Articles 11 and 43 of the “Administrative Measures on Major Asset Reorganization of Listed Companies”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated